Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

FDA Fast Tracks JSKN003 in Ovarian Cancer

October 30th 2025, 3:00pm

Article

The FDA granted fast track designation to JSKN003 in platinum-resistant recurrent epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

Understanding Your Stage 2 Ovarian Cancer

October 21st 2025, 7:00pm

Article

Learn what stage 2 ovarian cancer means, how it’s diagnosed, treatment options like surgery and chemotherapy, and key questions to ask your oncologist.

Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer

October 19th 2025, 7:50pm

Article

Platinum chemo with Imfinzi, Avastin, and Lynparza improved progression-free survival versus chemo and Avastin but did not extend overall survival.

Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

October 18th 2025, 8:16pm

Article

Clinical trial results showed favorable results with Keytruda-based therapy in this ovarian cancer population.

FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer

September 15th 2025, 3:00pm

Article

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.

FDA Accepts New Drug Application for Relacorilant in Ovarian Cancer

September 11th 2025, 3:00pm

Article

The FDA has accepted a new drug application for relacorilant as a treatment for patients with platinum-resistant ovarian cancer.

An Expert Discusses Ovarian Cancer Basics, From Staging to Treatment

September 2nd 2025, 8:00pm

Article

CURE spoke with Dr. Ryan Kahn of Miami Cancer Institute for Ovarian Cancer Awareness Month.

Expert Discusses Treatment Advances During Ovarian Cancer Awareness Month

September 2nd 2025, 1:00pm

Video

Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian cancer in decades.

How Ovarian Cancer Treatment May Affect Fertility

August 29th 2025, 9:00pm

Article

Women diagnosed with ovarian cancer should consult a fertility specialist immediately, as egg or embryo freezing is most effective before treatment starts.

FDA Gives Fast Track Designation to Stenoparib in Advanced Ovarian Cancer

August 28th 2025, 4:00pm

Article

The FDA has granted fast track designation to stenoparib, an investigational therapy for patients with advanced ovarian cancer.